Overexpression of helper T cell type 2-related molecules in the skin of patients with eosinophilic dermatosis of hematologic malignancy

血液系统恶性肿瘤嗜酸性皮肤病患者皮肤中辅助性T细胞2型相关分子的过度表达

阅读:7
作者:Roberto Maglie, Filippo Ugolini, Francesco De Logu, Romina Nassini, Sara Simi, Pamela Nardiello, Elisa Pasqualini, Gianna Baroni, Elena Del Bianco, Daniela Massi, Emiliano Antiga

Background

Eosinophilic dermatosis of hematologic malignancy (EDHM) is a rare dermatosis associated with blood tumors.

Conclusions

Targeting Th2-related molecules, in particular IL-4, holds promise for EDHM management.

Methods

Immunohistochemical and immunofluorescence analysis were performed in 12 skin samples of EDHM, 11 samples of bullous pemphigoid (BP), and 5 samples from healthy controls (HC). Serum levels of interleukin (IL) 4 were analyzed in 11 patients with EDHM, 11 BP patients, and 5 HC by enzyme-linked immunosorbent assay.

Objective

To characterize the expression of T-cell and B-cell markers and pruritogenic mediators in EDHM skin.

Results

T-cell markers, including clusters of differentiation (CD) 3, CD4, CD8, and CD5 were significantly overexpressed in EDHM and BP skin compared to HC. A predominance of CD4+ over CD8+ cells and GATA3+ (helper T cell type 2 [Th2] marker) over T-bet+ (Th1 marker) cells were observed. FOXP3 expression was increased but the FOXP3/CD4 ratio was low. B-cell markers were under-represented, without significant differences between the 3 groups. IL-4 and IL-31 were significantly overexpressed in EDHM and BP compared to HC and colocalized with the Th2-associated marker GATA3. Eotaxin-1 was significantly overexpressed in EDHM compared to BP and HC. IL-4 serum concentration was significantly increased in EDHM and BP compared to HC. Limitations: Small sample size; retrospective design. Conclusions: Targeting Th2-related molecules, in particular IL-4, holds promise for EDHM management.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。